260 related articles for article (PubMed ID: 30636741)
1. Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis.
Iulita MF; Ganesh A; Pentz R; Flores Aguilar L; Gubert P; Ducatenzeiler A; Christie S; Wilcock GK; Cuello AC
J Alzheimers Dis; 2019; 67(1):327-341. PubMed ID: 30636741
[TBL] [Abstract][Full Text] [Related]
2. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
3. An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation.
Iulita MF; Ower A; Barone C; Pentz R; Gubert P; Romano C; Cantarella RA; Elia F; Buono S; Recupero M; Romano C; Castellano S; Bosco P; Di Nuovo S; Drago F; Caraci F; Cuello AC
Alzheimers Dement; 2016 Nov; 12(11):1132-1148. PubMed ID: 27452424
[TBL] [Abstract][Full Text] [Related]
4. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
[TBL] [Abstract][Full Text] [Related]
5. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
Hanon O; Vidal JS; Lehmann S; Bombois S; Allinquant B; Tréluyer JM; Gelé P; Delmaire C; Blanc F; Mangin JF; Buée L; Touchon J; Hugon J; Vellas B; Galbrun E; Benetos A; Berrut G; Paillaud E; Wallon D; Castelnovo G; Volpe-Gillot L; Paccalin M; Robert PH; Godefroy O; Dantoine T; Camus V; Belmin J; Vandel P; Novella JL; Duron E; Rigaud AS; Schraen-Maschke S; Gabelle A;
Alzheimers Dement; 2018 Jul; 14(7):858-868. PubMed ID: 29458036
[TBL] [Abstract][Full Text] [Related]
6. Multiplex immunoassay measurement of amyloid-β
Vogelgsang J; Shahpasand-Kroner H; Vogelgsang R; Streit F; Vukovich R; Wiltfang J
Exp Brain Res; 2018 May; 236(5):1241-1250. PubMed ID: 29480353
[TBL] [Abstract][Full Text] [Related]
7. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
8. Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes.
Verberk IMW; Slot RE; Verfaillie SCJ; Heijst H; Prins ND; van Berckel BNM; Scheltens P; Teunissen CE; van der Flier WM
Ann Neurol; 2018 Nov; 84(5):648-658. PubMed ID: 30196548
[TBL] [Abstract][Full Text] [Related]
9. Association of Midlife Plasma Amyloid-β Levels With Cognitive Impairment in Late Life: The ARIC Neurocognitive Study.
Sullivan KJ; Blackshear C; Simino J; Tin A; Walker KA; Sharrett AR; Younkin S; Gottesman RF; Mielke MM; Knopman D; Windham BG; Griswold ME; Mosley TH
Neurology; 2021 Sep; 97(11):e1123-e1131. PubMed ID: 34349010
[TBL] [Abstract][Full Text] [Related]
10. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
[TBL] [Abstract][Full Text] [Related]
11. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
12. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
13. Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.
Mielke MM; Hagen CE; Wennberg AMV; Airey DC; Savica R; Knopman DS; Machulda MM; Roberts RO; Jack CR; Petersen RC; Dage JL
JAMA Neurol; 2017 Sep; 74(9):1073-1080. PubMed ID: 28692710
[TBL] [Abstract][Full Text] [Related]
14. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
Oikonomidi A; Tautvydaitė D; Gholamrezaee MM; Henry H; Bacher M; Popp J
J Alzheimers Dis; 2017; 60(1):273-281. PubMed ID: 28826184
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
Mattsson-Carlgren N; Janelidze S; Palmqvist S; Cullen N; Svenningsson AL; Strandberg O; Mengel D; Walsh DM; Stomrud E; Dage JL; Hansson O
Brain; 2020 Dec; 143(11):3234-3241. PubMed ID: 33068398
[TBL] [Abstract][Full Text] [Related]
17. A Novel Plasma Based Biomarker of Alzheimer's Disease.
Bradley-Whitman MA; Abner E; Lynn BC; Lovell MA
J Alzheimers Dis; 2015; 47(3):761-71. PubMed ID: 26401710
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD
J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385
[TBL] [Abstract][Full Text] [Related]
19. Endothelial-derived plasma exosome proteins in Alzheimer's disease angiopathy.
Abner EL; Elahi FM; Jicha GA; Mustapic M; Al-Janabi O; Kramer JH; Kapogiannis D; Goetzl EJ
FASEB J; 2020 Apr; 34(4):5967-5974. PubMed ID: 32157747
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort.
Foley KE; Winder Z; Sudduth TL; Martin BJ; Nelson PT; Jicha GA; Harp JP; Weekman EM; Wilcock DM
Alzheimers Dement; 2024 Feb; 20(2):1374-1386. PubMed ID: 38011580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
